Veracyte (VCYT) Invested Capital (2012 - 2026)

Veracyte has disclosed Invested Capital across 15 years of filings, most recently posting $1.3 billion for Q1 2026.

• Invested Capital for Q1 2026 came in at $1.3 billion, up 11.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 billion (up 11.25% YoY), and the FY2025 annual result was $1.3 billion, up 9.89% from the prior year.
• Invested Capital came in at $1.3 billion for Q1 2026 at Veracyte, up from $1.3 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $1.3 billion in Q1 2026 to a low of $1.0 billion in Q4 2023.
• The 5-year median for Invested Capital is $1.1 billion (2024), against an average of $1.2 billion.
• Across the five-year window, Invested Capital slipped 5.3% in 2022 and grew 13.97% in 2024, its largest moves.
• Veracyte's Invested Capital stood at $1.1 billion in 2022, then fell by 2.75% to $1.0 billion in 2023, then advanced by 13.97% to $1.2 billion in 2024, then advanced by 9.89% to $1.3 billion in 2025, then advanced by 2.63% to $1.3 billion in 2026.
• The last three Invested Capital figures came in at $1.3 billion (Q1 2026), $1.3 billion (Q4 2025), and $1.3 billion (Q3 2025), per Business Quant data.